Showing results (891-900 of 1,142) with videos related to

Sort By:
Pageof 115
Experimental Neurology|June 10, 2026
Aged oligodendrocyte progenitors retain the capacity to respond to an inflammatory insultEmily E Fresenko, Kaitlin E Kaiser, Benjamin J Burson, et al.
Scientific Reports|April 2, 2020
Author Correction: Development and performance of prototype serologic and molecular tests for hepatitis delta infectionKelly E Coller, Emily K Butler, Ka-Cheung Luk, et al.
Journal of Hepatology|January 17, 2012
High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitisSven Pischke, Juliane Gösling, Ilka Engelmann, et al.
The Journal of Infectious Diseases|March 30, 2012
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1Kerstin A Stegmann, Niklas K Björkström, Sandra Ciesek, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 3, 2014
Comprehensive phenotyping of regulatory T cells after liver transplantationAnna Gronert Álvarez, Paraskevi Fytili, Pothakamuri V Suneetha, et al.
Hepatology (Baltimore, Md.)|January 26, 2013
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patientsHeiner Wedemeyer, Donald Jensen, Robert Herring, et al.
Vaccine|June 30, 2009
Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis CHeiner Wedemeyer, Elisabeth Schuller, Verena Schlaphoff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitisKalliopi Zachou, Cihan Yurdaydin, Uta Drebber, et al.
Zeitschrift Fur Gastroenterologie|May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-RegistryEva Katharina Messer, David Petroff, Jörn Schattenberg, et al.
Toxicology and Applied Pharmacology|May 21, 2025
Dual therapy for amanita phalloides-induced acute liver failure in mice: A combination of etanercept and alpha-1 antitrypsinNils Jedicke, Nataliia Petriv, Huizhen Suo, et al.
Pageof 115